Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at...
Vous n'êtes pas connecté
An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center (MSK). The new technology has the potential to improve cancer care with the very [...]
Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at...
Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients...
A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024...
Scientists at Weill Cornell Medicine have made a groundbreaking discovery about the immune system that could improve treatments for chronic...
The Ministry of Health has always regarded the promotion of scientific research and the development of new products as one of its top priorities.
Artificial intelligence (AI) has enabled scientists at the University of British Columbia to discover a high-risk endometrial cancer type and a...
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
Tanzania has opened the first Emergency Operation and Communication Center for predicting floods and droughts Read Full Article at RT.com
Researchers have identified a biomarker that can help determine which medlinkrenal cancer/medlink patients are at a higher risk of recurrence. The
The gene signature for renal cancer can help clinicians identify recurrence risk earlier and potentially guide patient treatment strategies.